As previously reported for the oral cavity and oropharynx, low CD44 expression is correlated with increasing metastasizing behavior and poor prognosis [13,14], while in laryngeal carcinomas, high CD44 expression is correlated with increasing metastasizing behavior and radiotherapy resistance [15,16,17]. This evidence concerns the gene CD44 and laryngeal carcinoma.